PDF Results for "Nhl Bfm"

NHL Committee Report 3 Joint Sessions (NHL-EICNHL, NHL-ECT and NHL-IMM) Andishe Attarbaschi Angelo Rosolen 24th annual meeting of the international BFM (i-BFM

BFM B Cell Protocol-Cycle A (modified NHL-BFM 90 Protocol) Block A Course _____ Name: _____ RN:_____ Weight _____kg (most recent ), Height _____cm, BSA ...

In trial NHL-BFM 95, duration of methotrexate (MTX) in-fusion was randomly assigned in therapy group II for B-NHL within each therapy branch: patients received MTX ...

NHL-BFM 90, 95 Therapy Groups • Lymphoblastic Lymphoma • Precursor-B-cell • T-cell • Peripheral T-cell Lymphoma • Burkitt/B-ALL • Diffuse large cell B-NHL

Relapsed or Refractory Anaplastic Large-Cell Lymphoma in Children and Adolescents After Berlin-Frankfurt-Muenster (BFM)–Type First-Line Therapy: A BFM-Group Study

NHL/BFM-95 intensified (B2) Subjects with localized (stage I and II) lymphoblastic lymphoma are non-randomly assigned to receive standard CCG BFM therapy with reduced

Alfred Reiter, M.D. NHL-BFM Study Center Children´s University Hospital Division of Ped. Hematology and Oncology Justus-Liebig-University Giessen, Germany

6 82% for IPCG cohort might indicate insufficient frontline treatment at least for a subset of patients. In contrast, the intensive NHL-BFM treatment might reduce the ...

Fourth International Symposium on Childhood, ... and Adolescent Non Hodgkin´s Lymphoma: BFM Perspective Wilhelm Woessmann, MD, NHL-BFM Study Center , Germany

Münster (NHL-BFM) multicenter trials, and the cohort was representative of the German population. Results

Case Study SubcutaneousPanniculitis-LikeT-CellLymphoma(SPTCL) withHemophagocytosis(HPS):SuccessfulTreatment UsingHigh-DoseChemotherapy(BFM-NHL&ALL-90)

Curriculum vitae Martin Schrappe, M.D., FRCP (Glasg) ... 1990-1995 Coordinator for trials ALL-BFM 90, and NHL-BFM 90 . 1995-1998 Vice-Chairman, ALL-BFM Study Group .

arahojkinis limfomis multicentruli Terapiuli oqmi bavSvTa asakSi B-NHL BFM 2004 - 1 -

RESULTS OF THE POOLED DATA OF THE SFCE LMB 96 AND 2001 AND THE BFM 95 AND 04 STUDIES C Patte, A Aupérin, M Zimmerman, A Reiter for the SFCE LMB and GPOH BFM study groups

and adolescents: israel society of Pediatric Hematology Oncology retrospective study Ofrat Beyar Katz1, ... Objectives: To assess the outcome of the NHL-BFM-95

Anaplastic Large Cell Lymphoma Overview Lymphoma is the most common blood cancer. The two main forms of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin

N = 2,381Therapy studies NHL-BFM 86, 90, 95 Non-Hodgkin Lymphoma of Childhood. Precursor B-cell Lymphoblastic lymphoma 5 % Precursor T-cell Lymphoblastic lymphoma 15 %

Aara - hojkinis limfoma (NHD) saqarTvelos pediatr-hematologTa da onko hematologTa kavSiri ... B-NHL BFM 2004 – programa, romelic Targmnilia qarTul enaze da

MONITORING THE ASPARAGINASE ACTIVITY AND ASPARAGINE LEVELS IN CHILDREN WITH ACUTE ... protokolu ALL/NHL-BFM 95 po podání dvou různých preparátů asparaginasy.

session 9: pediatric lymphoma 088 with the lmb and bfm protocols, children and adolescents with b-cell non hodgkin’s lymphoma and mature b-cell leukemia have ...

INTRODUCTION: Treatment results for pediatric non-Hodgkin’s lymphoma (NHL) continue to improve inter-nationally. ... (BFM-NHL-90), and since 1997 the BFM-

the October or November issue of . British Journal of ... Treatment and Prognosis of Childhood and Adolescent B-NHL: LMB and BFM Perspective Catherine Patte, MD ...

Aseptic Osteonecrosis in ... a report of the Berlin-Frankfurt-Mu¨nster Group Trial NHL-BFM ... Mann G, Dworzak M, et al. Malignant non-Hodgkin’s lymphoma of ...

Subcutaneous Nodules as Initial Presentation of Burkitt Lymphoma in HIV-negative Child ... Frankfurt-Mu¨nster group trial NHL-BFM 90. Blood. 1999;94: 3294–3306. 4.

a range from 48 to 120 months. Table 1 summarizes the demographics, stages, and treatment groups of the patients. All patients were treated using the NHL-BFM 90 protocol,

aaaand non-Hodgkin’s lymphoma (NHL). Pegylated ASNase (PEG-ASNase, Oncaspar TM) is an ... ALL/NHL-BFM REZ protocol as well as the adult GMALL

B-NHL BFM Rituximab (2004-) 6.3 ALCL 99 (2000-) 6.4 ALCL ... Non-Hodgkin Lymphoma (NHL), hematopoetic stem cell transplantation If not all areas within one speciality ...

The clinical management of tumour lysis syndrome in haematological malignancies ... (NHL) enrolled on the NHL-BFM 90 ... leukaemia and non-Hodgkin’s lymphoma in four

of the International BFM Study Group May 17 – 19, 2013 PROGRAM Audimax ... a future I-BFM trial, O. Abla 17:35 NHL in DNA mismatch repair syndromes - an I-

Key words Non-Hodgkin′s lymphoma, diffuse large B-cell lymphoma, pediatric, chemotherapy, ... rate of pediatric DLBCL patients treated with the B-NHL-BFM-90/95

AML-BFM 2004)] and non-Hodgkin lymphoma [NHL (NHL-BFM 95, LBL Register or EURO-LB 02)], Hodgkin disease (GPOH 2002 PILOT or EuroNet-PHL-C1) or solid tumors [Ewing sarcoma

asparaginase, especially when administered in combination with other antineoplastic agents. ... nhl-BFm 95 protocols. Br J Haematol. 2000;110(2):379-384. 9.

ORIGINAL RESEARCH Open Access Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients

NHL-BFM ALCL99 with ALCL relapse, BMT ... ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol.

NHL-BFM-90 and -95 CWS-96, EICCES/ ... Treatment of pediatric non-Hodgkin’s lymphoma in Hungary: ... Cancer Genetics Cytogenetics, 142(2), ...

INTRODUCTION: Treatment results for pediatric non-Hodgkin’s lymphoma (NHL) continue to improve inter-nationally. ... (BFM-NHL-90), and since 1997 the BFM-

Chemotherapy according to the ALCL-99-NHL-BFM protocol was initiated and resulted in a complete remission after two cycles. This case illustrates the unusual